RedHill Biopharma (RDHL) Inventory Average: 2017-2025
Historic Inventory Average for RedHill Biopharma (RDHL) over the last 6 years, with Jun 2025 value amounting to $3.4 million.
- RedHill Biopharma's Inventory Average fell 16.76% to $3.4 million in Q2 2025 from the same period last year, while for Jun 2025 it was $3.4 million, marking a year-over-year decrease of 16.76%. This contributed to the annual value of $4.0 million for FY2024, which is 47.79% down from last year.
- According to the latest figures from Q2 2025, RedHill Biopharma's Inventory Average is $3.4 million, which was down 8.52% from $3.7 million recorded in Q4 2024.
- RedHill Biopharma's Inventory Average's 5-year high stood at $13.0 million during Q2 2022, with a 5-year trough of $3.4 million in Q2 2025.
- Moreover, its 3-year median value for Inventory Average was $4.4 million (2023), whereas its average is $5.0 million.
- In the last 5 years, RedHill Biopharma's Inventory Average surged by 239.77% in 2021 and then slumped by 60.46% in 2023.
- Quarterly analysis of 5 years shows RedHill Biopharma's Inventory Average stood at $10.4 million in 2021, then rose by 13.35% to $11.8 million in 2022, then tumbled by 60.46% to $4.7 million in 2023, then fell by 20.08% to $3.7 million in 2024, then decreased by 16.76% to $3.4 million in 2025.
- Its Inventory Average stands at $3.4 million for Q2 2025, versus $3.7 million for Q4 2024 and $4.1 million for Q2 2024.